U.S. Physical Therapy, Inc. (NYSE:USPH - Get Free Report) Director Bernard A. Harris, Jr. sold 2,000 shares of the firm's stock in a transaction dated Tuesday, November 12th. The stock was sold at an average price of $92.95, for a total transaction of $185,900.00. Following the completion of the transaction, the director now directly owns 16,726 shares in the company, valued at $1,554,681.70. This represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink.
U.S. Physical Therapy Price Performance
Shares of USPH opened at $91.87 on Thursday. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.88 and a current ratio of 1.78. The firm has a market cap of $1.39 billion, a PE ratio of 97.73, a PEG ratio of 4.16 and a beta of 1.38. The firm's 50 day moving average price is $84.02 and its 200 day moving average price is $91.26. U.S. Physical Therapy, Inc. has a twelve month low of $76.18 and a twelve month high of $113.63.
U.S. Physical Therapy (NYSE:USPH - Get Free Report) last posted its quarterly earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.82 by ($0.09). The business had revenue of $167.19 million during the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.11% and a net margin of 3.54%. The business's revenue for the quarter was up 10.4% on a year-over-year basis. During the same period last year, the company earned $0.76 EPS. As a group, research analysts expect that U.S. Physical Therapy, Inc. will post 2.67 EPS for the current fiscal year.
U.S. Physical Therapy Dividend Announcement
Financial Prophecy
From Porter & Company | Ad
The Magnificent 7 could be in for a world of pain…
And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock.
The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on.
It’s called The Final Frontier.
Including the name of the #1 company to buy.
The company also recently declared a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be issued a $0.44 dividend. This represents a $1.76 annualized dividend and a yield of 1.92%. The ex-dividend date is Friday, November 15th. U.S. Physical Therapy's dividend payout ratio is 187.23%.
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently bought and sold shares of the company. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of U.S. Physical Therapy by 57.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,631 shares of the company's stock worth $223,000 after buying an additional 956 shares during the period. BNP Paribas Financial Markets raised its stake in shares of U.S. Physical Therapy by 283.0% during the 3rd quarter. BNP Paribas Financial Markets now owns 16,842 shares of the company's stock worth $1,425,000 after purchasing an additional 12,445 shares in the last quarter. Quantbot Technologies LP boosted its holdings in shares of U.S. Physical Therapy by 57.6% in the 3rd quarter. Quantbot Technologies LP now owns 10,876 shares of the company's stock valued at $920,000 after buying an additional 3,973 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of U.S. Physical Therapy in the 3rd quarter valued at about $356,000. Finally, First Horizon Advisors Inc. raised its stake in U.S. Physical Therapy by 25.1% in the third quarter. First Horizon Advisors Inc. now owns 1,486 shares of the company's stock valued at $126,000 after buying an additional 298 shares during the period.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on USPH. Barrington Research reiterated an "outperform" rating and issued a $108.00 target price on shares of U.S. Physical Therapy in a research report on Thursday, November 7th. Bank of America reaffirmed a "neutral" rating and issued a $90.00 price target (down previously from $114.00) on shares of U.S. Physical Therapy in a report on Monday, October 7th. Finally, StockNews.com raised U.S. Physical Therapy from a "sell" rating to a "hold" rating in a research note on Wednesday, August 21st.
Check Out Our Latest Research Report on U.S. Physical Therapy
U.S. Physical Therapy Company Profile
(
Get Free Report)
U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].
